Lantern Pharma Inc (NASDAQ: LTRN) is 69.28% higher on its value in year-to-date trading and has touched a low of $2.79 and a high of $11.99 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LTRN stock was last observed hovering at around $4.17 in the last trading session, with the day’s gains setting it 1.23%.
Currently trading at $5.40, the stock is 42.38% and 52.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.48 million and changing 29.50% at the moment leaves the stock 24.02% off its SMA200. LTRN registered 30.75% gain for a year compared to 6-month loss of 22.17%. The firm has a 50-day simple moving average (SMA 50) of $3.55034 and a 200-day simple moving average (SMA200) of $4.35401.
The stock witnessed a 71.70% gain in the last 1 month and extending the period to 3 months gives it a 59.29%, and is 50.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.17% over the week and 13.78% over the month.
Lantern Pharma Inc (LTRN) has around 21 employees, a market worth around $58.24M and $0.00M in sales. Distance from 52-week low is 93.55% and -54.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-71.53%).
The EPS is expected to shrink by -30.27% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Lantern Pharma Inc (LTRN) Top Institutional Holders
49.0 institutions hold shares in Lantern Pharma Inc (LTRN), with institutional investors hold 28.27% of the company’s shares. The shares outstanding are 10.78M, and float is at 8.04M with Short Float at 2.42%. Institutions hold 24.10% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 0.36 million shares valued at $1.7 million. The investor’s holdings represent 3.3857% of the LTRN Shares outstanding. As of 2024-06-30, the second largest holder is NEWEDGE ADVISORS, LLC with 0.16 million shares valued at $0.73 million to account for 1.4626 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 86347.0 shares representing 0.8038% and valued at over $0.4 million, while RENAISSANCE TECHNOLOGIES LLC holds 0.7614 of the shares totaling 81800.0 with a market value of $0.38 million.
Lantern Pharma Inc (LTRN) Insider Activity
The most recent transaction is an insider sale by Fletcher Aaron G.L., the company’s 10% Owner. SEC filings show that Fletcher Aaron G.L. sold 20,000 shares of the company’s common stock on May 24 ’24 at a price of $6.33 per share for a total of $0.13 million. Following the sale, the insider now owns 57467.0 shares.
Lantern Pharma Inc disclosed in a document filed with the SEC on May 23 ’24 that Fletcher Aaron G.L. (10% Owner) sold a total of 10,000 shares of the company’s common stock. The trade occurred on May 23 ’24 and was made at $6.25 per share for $62500.0. Following the transaction, the insider now directly holds 59326.0 shares of the LTRN stock.
Still, SEC filings show that on Feb 28 ’24, Fletcher Aaron G.L. (10% Owner) disposed off 74,297 shares at an average price of $4.85 for $0.36 million. The insider now directly holds 62,088 shares of Lantern Pharma Inc (LTRN).
